1. Clinical Significance and Role of TK1, CEA, CA 19-9 and CA 72-4 levels in Diagnosis of Colorectal Cancers

Volume 21, Issue 11, November 2020, Pages 3133-3136

Swarnima Singh; Rakesh Kumar; Uday Kumar; Rekha kumari

• View Article
• PDF 281.03 K

2. Comparative Study of Blood, Tissue and Serum Levels of Carcinoembryonic Antigen (CEA) Detection in Breast Cancer

Volume 20, Issue 10, October 2019, Pages 2979-2985

Neda Moazzezy; Saeid Bouzari; Mana Oloomi

• View Article
• PDF 313.22 K

3. Three Markers in Cancerous and Healthy Cells of Patients with Non-Small-Cell Lung Carcinoma (NSCLC)

Volume 20, Issue 8, August 2019, Pages 2281-2285

Hamidreza Jamaati; Adnan Khosravi; Atefeh Abedini; Arda Kiani; Payam Tabarsi; Hossein Dargahi; Naghmeh Bahrami; Mehdi Kazempour Dizaji; Farahnaz Sadegh Beigee; Mihan Pourabdollah; Abbas Gheysouri; Nasser Ahmadian; Masoum Abniki; Abdolreza Mohamadnia; Aliakbar Velayati

• View Article
• PDF 257.8 K

4. The Application Value of Serum HE4 in the Diagnosis of Lung Cancer

Volume 20, Issue 8, August 2019, Pages 2405-2407

Yuhui Wang; Zhenming Wang; Yansheng Ding; Fengqiang Sun; Xiaomei Ding

• View Article
• PDF 298.07 K

5. Prognostic Significance of a Tumor Marker Index Based on Preoperative Serum Carcinoembryonic Antigen and Krebs von den Lungen-6 Levels in Non-Small Cell Lung Cancer

Volume 18, Issue 1, January 2017, Pages 287-291

Masaki Tomita; Takanori Ayabe; Eiichi Chosa; Naohiro Nose; Kunihide Nakamura

• View Article
• PDF 337.32 K

6. New Prognostic Scoring System for Incurable Stage IV Colorectal Cancer

Volume 17, Issue 2, February 2016, Pages 597-601

• View Article
• PDF 410.34 K

7. Effects of Fresh Yellow Onion Consumption on CEA, CA125 and Hepatic Enzymes in Breast Cancer Patients: A Double- Blind Randomized Controlled Clinical Trial

Volume 16, Issue 17, December 2015, Pages 7517-7522

• View Article
• PDF 548.3 K

8. Applicative Value of Serum CA19-9, CEA, CA125 and CA242 in Diagnosis and Prognosis for Patients with Pancreatic Cancer Treated by Concurrent Chemoradiotherapy

Volume 16, Issue 15, December 2015, Pages 6569-6573

• View Article
• PDF 455.85 K

9. Comparative Study of Carcinoembryonic Antigen Tumor Marker in Stomach and Colon Cancer Patients in Khyber Pakhtunkhwa

Volume 16, Issue 11, November 2015, Pages 4497-4502

• View Article
• PDF 878.33 K

10. Secondary Circulating Tumor Cells (CTCs) but not Primary CTCs are Associated with the Clinico-Pathological Parameters in Chilean Patients With Colo-Rectal Cancer

Volume 16, Issue 11, November 2015, Pages 4745-4749

• View Article
• PDF 585.17 K

11. Correlation between Serum Carcinoembryonic Antigen Level and Histologic Subtype in Resected Lung Adenocarcinoma

Volume 16, Issue 9, September 2015, Pages 3857-3860

• View Article
• PDF 383.53 K

12. Alpha-fetoprotein (AFP) Elevation Gastric Adenocarcinoma and Importance of AFP Change in Tumor Response Evaluation

Volume 16, Issue 5, May 2015, Pages 2003-2007

• View Article
• PDF 532.98 K

13. A Prognostic Model To Predict Survival In Stage III Colon Cancer Patients Based on Histological Grade, Preoperative Carcinoembryonic Antigen Level and the Neutrophil Lymphocyte Ratio

Volume 16, Issue 2, February 2015, Pages 747-751

• View Article
• PDF 463.62 K

14. Tumor Markers in Serum and Ascites in the Diagnosis of Benign and Malignant Ascites

Volume 16, Issue 2, February 2015, Pages 719-722

• View Article
• PDF 420.04 K

15. Clinical Utility of Haptoglobin in Combination with CEA, NSE and CYFRA21-1 for Diagnosis of Lung Cancer

Volume 15, Issue 22, December 2014, Pages 9611-9614

• View Article
• PDF 555.86 K

16. Prognostic Model Built on Blood-based Biomarkers in Patients with Metastatic Colorectal Cancer

Volume 15, Issue 17, December 2014, Pages 7327-7331

• View Article
• PDF 547.28 K

17. Preliminary Evaluation of Clinical Utility of CYFRA 21-1, CA 72-4, NSE, CA19-9 and CEA in Stomach Cancer

Volume 15, Issue 12, December 2014, Pages 4933-4938

• View Article
• PDF 431.05 K

18. Evaluation of Prognostic Factors and Survival Results in Pancreatic Carcinomas in Turkey

Volume 14, Issue 11, November 2013, Pages 6573-6578

• View Article
• PDF 473.55 K

19. Clinical Observations on the Association Between Diagnosis of Lung Cancer and Serum Tumor Markers in Combination

Volume 14, Issue 7, July 2013, Pages 4369-4371

• View Article
• PDF 343.52 K

20. CEA and CA 19-9 are Still Valuable Markers for the Prognosis of Colorectal and Gastric Cancer Patients

Volume 14, Issue 7, July 2013, Pages 4289-4294

• View Article
• PDF 342.14 K

21. Expression and Significance of TSGF, CEA and AFP in Patients Before and after Radical Surgery for Colon Cancer

Volume 14, Issue 6, June 2013, Pages 3877-3880

• View Article
• PDF 422.42 K

22. Serum Carbohydrate Antigen 19-9 as an Indicator of LiverMetastasis in Colorectal Carcinoma Cases

Volume 14, Issue 2, February 2013, Pages 909-913

• View Article
• PDF 467.61 K

23. Requests for Tumor Marker Tests in Turkey Without Indications and Frequency of Elevation in Benign Conditions

Volume 13, Issue 12, December 2012, Pages 6485-6489

• View Article
• PDF 896.24 K

24. Preoperative Serum Carcinoembryonic Antigen, Carbohydrate Antigen19-9 and Carbohydrate Antigen 125 as Prognostic Factors for Recurrence-free Survival in Colorectal Cancer

Volume 12, Issue 5, May 2011, Pages 1251-1256

• View Article
• PDF 442.43 K